TOP-289 Artificial intelligence-based measurement of non-alcoholic steatohepatitis is an accurate tool for clinical trial enrollment and end point assessment
The DOI matches its Crossref record.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, positive results were reported when using a proprietary AI-based tool (AIM-MASH AI Assist∗, PathAI, US) to assess liver biopsies of 1,451 patients with/without cirrhosis for MASH clinical trial enrolment and endpoint assessment.38”
From Use of artificial intelligence for liver diseases: A survey from the EASL congress 2024 (2024) · cites this paper as [38]
Citations
Cites
Still being checked.
Cited by
Use of artificial intelligence for liver diseases: A survey from the EASL congress 2024
Žigutytė, L., Sorz-Nechay, T., Clusmann, J., & Kather, J. N. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101209 · Cited by 33
Metadata
- Authors
- Pulaski, H., Hou, H., Resnick, M., Harrison, S. A., Sanyal, A. J., Ratziu, V., Burt, A., Bedossa, P., Montalto, M., & Wack, K.
- ORCID
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2024-06
- Volume
- 80
- Pages
- S507
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W4399461794
- Cited by
- 1
- References
- 0
- Citations by year
- 2024: 1
- Type
- conference abstract
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Journal of Hepatology (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Keywords
- nonalcoholic steatohepatitis, artificial intelligence, clinical trial recruitment, end-point assessment, liver fibrosis, non-invasive diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TOP-289 Artificial intelligence-based measurement of non-alcoholic steatohepatitis is an accurate tool for clinical trial enrollment and end point assessment. https://app.cochat.ai/papers/10.1016/s0168-8278(24)01537-x
- The paper
- Pulaski, H., Hou, H., Resnick, M., Harrison, S. A., Sanyal, A. J., Ratziu, V., Burt, A., Bedossa, P., Montalto, M., & Wack, K. (2024). TOP-289 Artificial intelligence-based measurement of non-alcoholic steatohepatitis is an accurate tool for clinical trial enrollment and end point assessment. Journal of Hepatology. https://doi.org/10.1016/s0168-8278(24)01537-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.